Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Oct 1:203:99-106.
doi: 10.1016/j.drugalcdep.2019.05.020. Epub 2019 Aug 1.

Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers

Affiliations
Randomized Controlled Trial

Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers

Adam M Leventhal et al. Drug Alcohol Depend. .

Abstract

Background: E-cigarette regulations targeting products that disproportionately appeal to never-smokers may optimize population health. This laboratory study of young adults tested whether differences in appeal between e-cigarettes with non-tobacco-flavored (vs. tobacco-flavored) and nicotine-containing (vs. nicotine-free) solutions varied by smoking history.

Methods: Current (N = 53), former (N = 25), and never (N = 22) cigarette smokers who vape (Mean[SD] age = 25.4[4.4] years) administered standardized e-cigarette doses varied by a Flavor (fruit, menthol, tobacco) × Nicotine (nicotine-containing [6 mg/mL], nicotine-free) within-subject double-blind design. Participants rated each dose's appeal (0-100 scale). Covariate-adjusted interactions tested whether smoking history moderated flavor and nicotine effects.

Results: Appeal was higher for fruit and menthol than tobacco flavors in each group. The fruit vs. tobacco appeal difference was greater in never smokers (fruit-tobacco estimate = 19.6) than current smokers (estimate = 12.1) but not former smokers (estimate = 12.6). The menthol vs. tobacco difference was greater in never smokers (menthol-tobacco estimate = 17.3) than former (estimate = 6.0) and current (estimate = 7.2) smokers. Appeal was lower for nicotine-containing than nicotine-free solutions in each group; this difference was greater in never smokers (nicotine-nicotine-free estimate = -17.3) than former (estimate = -7.0) and current (estimate = -10.6) smokers. Compared to tobacco flavors, nicotine's appeal-reducing effects were suppressed by fruit and menthol flavors in never smokers.

Conclusions: Higher appeal of non-tobacco-flavored (vs. tobacco-flavored) and lower appeal of nicotine-containing (vs. nicotine-free) e-cigarettes may be widespread in young adults but disproportionately amplified in never smokers. Non-tobacco flavors may suppress nicotine's appeal-lowering qualities in never smokers. The impact of regulating non-tobacco flavors in e-cigarettes may vary by smoking history.

Keywords: Flavors; Product appeal; Tobacco regulatory science; Young adults; e-Cigarettes.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

Dr. Goldenson left USC on February 10, 2019 and started as an employee of JUUL Labs as of March 4, 2019. He met criteria for authorship prior to leaving USC, and he had no role in revising the paper after leaving USC and joining JUUL Labs. There are no other interests declared by authors.

Figures

Fig. 1.
Fig. 1.
Product appeal of e-cigarettes with fruit, menthol, and tobacco flavored solutions, by smoking history (M ± SE). *Appeal rating significantly different between respective flavor and tobacco flavor within smoking history group (Pcorr < 0.05). †Extent of difference in appeal between respective flavor and tobacco flavor significantly differs between respective group and never smokers (Pcorr < 0.05). Appeal = Average of “liking,” “willingness-to-use-again” and “disliking” (reverse-scored) (range 0–100). Pcorr = P-value corrected for multiple tests to control study-wise false discovery rate of .05.
Fig. 2.
Fig. 2.
Product appeal of e-cigarettes with nicotine and nicotine-free solutions, by smoking history (M ± SE). *Appeal rating significantly different from nicotine-free within smoking history group (Pcorr < 0.05). †Extent of difference in appeal between nicotine and nicotine-free significantly differs between respective group and never smokers (Pcorr < 0.05). Appeal = Average of “liking,” “willingness-to-use-again” and “disliking” (reverse-scored) (range 0–100). Pcorr = P-value corrected for multiple tests to control study-wise false discovery rate of .05.
Fig. 3.
Fig. 3.
Product appeal of e-cigarettes with nicotine and nicotine-free solutions, by flavor and smoking history (M ± SE). *Extent of difference in appeal between nicotine and nicotine-free significantly differs between respective flavor and tobacco flavor within smoking history group (Pcorr < 0.05). Appeal = Average of “liking,” “willingness-to-use-again” and “disliking” (reverse-scored) (range 0–100). Pcorr = P-value corrected for multiple tests to control study-wise false discovery rate of .05.

Similar articles

Cited by

References

    1. Audrain-McGovern J, Strasser AA, Wileyto EP, 2016. The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. Drug Alcohol Depend 166, 263–267. - PMC - PubMed
    1. Barrington-Trimis JL, Leventhal AM, 2018. Adolescents’ use of “pod mod” e-cigarettes—urgent concerns. N. Engl. J. Med 379, 1099–1102. - PMC - PubMed
    1. Benjamini Y, Hochberg Y, 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc 57, 289–300.
    1. Berg CJ, 2015. Preferred flavors and reasons for e-cigarette use and discontinued use among never, current, and former smokers. Int. J. Public Health 61, 225–236. - PMC - PubMed
    1. Berteletti F, King J, Burch J, Toma Friedlaender A, 2017. Campaign for a revised tobacco products directive in the European Union: lessons learnt. Tob. Control 26, 464–467. - PubMed

Publication types